Metropolitan Life Insurance Company (MetLife)’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27
| Closed | -$18.1K | – | 2466 |
|
|
2023
Q1 | $18.1K | Sell |
27
-2
| -7% | -$1.34K | ﹤0.01% | 1929 |
|
|
2022
Q4 | $25.7K | Hold |
29
| – | – | ﹤0.01% | 1866 |
|
|
2022
Q3 | $32.3K | Buy |
29
+9
| +45% | +$10K | ﹤0.01% | 1752 |
|
|
2022
Q2 | $16.7K | Sell |
20
-12
| -38% | -$10K | ﹤0.01% | 2126 |
|
|
2022
Q1 | $49.5K | Sell |
32
-97
| -75% | -$150K | ﹤0.01% | 1595 |
|
|
2021
Q4 | $231K | Buy |
129
+18
| +16% | +$32.2K | ﹤0.01% | 1929 |
|
|
2021
Q3 | $366K | Sell |
111
-19
| -15% | -$62.6K | 0.01% | 1654 |
|
|
2021
Q2 | $574K | Buy |
+130
| New | +$574K | 0.01% | 1435 |
|